Cargando…

A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect

Glycosylphosphatidylinositol biosynthesis defect 15 is a rare autosomal recessive disorder due to biallelic loss of function of GPAA1. At the moment, less than twenty patients have been reported, usually compound heterozygous for GPAA1 variants. The main clinical features are intellectual disability...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontana, Paolo, Budillon, Alberto, Simeone, Domenico, Del Vecchio Blanco, Francesca, Caiazza, Martina, D’Amico, Alessandra, Lonardo, Fortunato, Nigro, Vincenzo, Limongelli, Giuseppe, Scarano, Gioacchino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379968/
https://www.ncbi.nlm.nih.gov/pubmed/37510348
http://dx.doi.org/10.3390/genes14071444
_version_ 1785080091209891840
author Fontana, Paolo
Budillon, Alberto
Simeone, Domenico
Del Vecchio Blanco, Francesca
Caiazza, Martina
D’Amico, Alessandra
Lonardo, Fortunato
Nigro, Vincenzo
Limongelli, Giuseppe
Scarano, Gioacchino
author_facet Fontana, Paolo
Budillon, Alberto
Simeone, Domenico
Del Vecchio Blanco, Francesca
Caiazza, Martina
D’Amico, Alessandra
Lonardo, Fortunato
Nigro, Vincenzo
Limongelli, Giuseppe
Scarano, Gioacchino
author_sort Fontana, Paolo
collection PubMed
description Glycosylphosphatidylinositol biosynthesis defect 15 is a rare autosomal recessive disorder due to biallelic loss of function of GPAA1. At the moment, less than twenty patients have been reported, usually compound heterozygous for GPAA1 variants. The main clinical features are intellectual disability, hypotonia, seizures, and cerebellar atrophy. We describe a 4-year-old male with a novel, homozygous variant. The patient presents with typical features, such as developmental delay, hypotonia, seizures, and atypical features, such as macrocephaly, preauricular, and cheek appendages. When he was 15 months, the cerebellum was normal. When he was 33 months old, after the molecular diagnosis, magnetic resonance imaging was repeated, showing cerebellar atrophy. This case extends the clinical spectrum of the GPAA1-related disorder and helps to delineate phenotypic differences with defects of other subunits of the transamidase complex.
format Online
Article
Text
id pubmed-10379968
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103799682023-07-29 A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect Fontana, Paolo Budillon, Alberto Simeone, Domenico Del Vecchio Blanco, Francesca Caiazza, Martina D’Amico, Alessandra Lonardo, Fortunato Nigro, Vincenzo Limongelli, Giuseppe Scarano, Gioacchino Genes (Basel) Case Report Glycosylphosphatidylinositol biosynthesis defect 15 is a rare autosomal recessive disorder due to biallelic loss of function of GPAA1. At the moment, less than twenty patients have been reported, usually compound heterozygous for GPAA1 variants. The main clinical features are intellectual disability, hypotonia, seizures, and cerebellar atrophy. We describe a 4-year-old male with a novel, homozygous variant. The patient presents with typical features, such as developmental delay, hypotonia, seizures, and atypical features, such as macrocephaly, preauricular, and cheek appendages. When he was 15 months, the cerebellum was normal. When he was 33 months old, after the molecular diagnosis, magnetic resonance imaging was repeated, showing cerebellar atrophy. This case extends the clinical spectrum of the GPAA1-related disorder and helps to delineate phenotypic differences with defects of other subunits of the transamidase complex. MDPI 2023-07-14 /pmc/articles/PMC10379968/ /pubmed/37510348 http://dx.doi.org/10.3390/genes14071444 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Fontana, Paolo
Budillon, Alberto
Simeone, Domenico
Del Vecchio Blanco, Francesca
Caiazza, Martina
D’Amico, Alessandra
Lonardo, Fortunato
Nigro, Vincenzo
Limongelli, Giuseppe
Scarano, Gioacchino
A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect
title A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect
title_full A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect
title_fullStr A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect
title_full_unstemmed A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect
title_short A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect
title_sort novel homozygous gpaa1 variant in a patient with a glycosylphosphatidylinositol biosynthesis defect
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379968/
https://www.ncbi.nlm.nih.gov/pubmed/37510348
http://dx.doi.org/10.3390/genes14071444
work_keys_str_mv AT fontanapaolo anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT budillonalberto anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT simeonedomenico anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT delvecchioblancofrancesca anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT caiazzamartina anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT damicoalessandra anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT lonardofortunato anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT nigrovincenzo anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT limongelligiuseppe anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT scaranogioacchino anovelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT fontanapaolo novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT budillonalberto novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT simeonedomenico novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT delvecchioblancofrancesca novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT caiazzamartina novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT damicoalessandra novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT lonardofortunato novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT nigrovincenzo novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT limongelligiuseppe novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect
AT scaranogioacchino novelhomozygousgpaa1variantinapatientwithaglycosylphosphatidylinositolbiosynthesisdefect